Phase 3 Trial to Evaluate the Efficacy and Safety of YYC506.
Clinical trial NCT04858308 · UNKNOWN
Trial details
- NCT number
- NCT04858308
- Sponsor
- Yooyoung Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-29
- Primary completion
- 2021-05-31
- Enrollment
- 554
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.